Recalls & Warnings January 24, 2013 Food for Health Warned for Manufacturing Violations and Drug Claims on Supplements On October 5, 2012, the FDA issued a warning letter to Food for Health International, LLC following a facility inspection which found the company's products, including Activz brand Vitamin D, Potassium Iodine, Organic Vitamin C, Whole 9 (a fruit and vegetable meal replacement shake) Control and VMA
Focus on #GLP1_RA #EJHF expert consensus document GLP-1 RAs & GIP/GLP-1 RA : #Semaglutide & #Tirzepatide Evidence of benefits in #HF Potential synergy with other #HF drugs Dosing, tolerability and safety considerations How to manage side effects Knowledge gaps & future directions
Serious Side Effects of Ozempic Though rare, Ozempic can cause serious side effects that require immediate medical attention
The global semaglutide market size was estimated at approximately USD 28.43 billion in 2024 and is projected to reach an astounding USD 93.6 billion by 2035, growing at an impressive CAGR of over 10%